RE:RE:RE:RE:RE:RE:RE:ANDA/NDAMultiple times, on conference it has been mentioned, the secrecey surrounding pharmaceutical development and its nature has clients prohibiting labs from updates until "milestones" are reached, they acknowledge relationships and are unable to even disclose the names of the clients. The next milestones are approval or rejection, and we won't know the names of our clients until then, nor will we receive updates ..imo